Accumulation Of Active Metabolite M-2 Predicts Overall Survival (Os) Of Chemorefractory Metastatic Colorectal Cancer Patients Treated With Regorafenib (Rego).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)